Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ozempic side effects how long does it last?What evidence supports sapropterin's effect on memory?When did lipitor's side effects become noticeable?Is exercise intensity affected by lipitor use?Is keytruda more effective than chemotherapy for treating cancer?
See the DrugPatentWatch profile for tigecycline
Why Is Tigecycline Considered Expensive? Tigecycline, an antibiotic used to treat various infections, has a relatively high cost due to its complex production process and patent protection. As of 2023, the medication costs approximately $500 to $600 per day, depending on the specific indication and dosage [1]. The high price is also attributed to a limited number of manufacturers, which can lead to shortages and increased costs [2]. How Does Tigecycline Compare to Other Antibiotics? When compared to other antibiotic medications, tigecycline is one of the more expensive options. According to a study published in the Journal of Managed Care & Pharmacy, tigecycline ranks among the top 10 most expensive antibiotics in the United States [3]. This high cost can lead to reduced usage and access to the medication for patients in need. What Happens When Patents Expire? The patent for tigecycline is set to expire in 2026, which could lead to generic versions of the medication becoming available. Generic tigecycline could potentially reduce the cost of the medication and increase its usage [4]. However, the actual impact of patent expiration on the cost and usage of tigecycline will depend on various factors, including market competition and regulatory approvals. Can Biosimilars Enter Before Patent Expiry? Under the Biologics Price Competition and Innovation Act (BPCIA), biosimilars can enter the market before the patent expires on the original product. This could potentially lead to increased competition and reduced costs for tigecycline. However, the development and approval of biosimilars for tigecycline are still underway, and it's unclear when they might become available [5]. Sources: [1] www.drugpatentwatch.com (Tigecycline patent and pricing information) [2] www.ncbi.nlm.nih.gov (Limited manufacturers and shortages of tigecycline) [3] Journal of Managed Care & Pharmacy (Ranking of expensive antibiotics in the US) [4] www.drugpatentwatch.com (Patent expiration dates for tigecycline) [5] www.ncbi.nlm.nih.gov (Biosimilar development and approval process for tigecycline)
Other Questions About Tigecycline :